These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29405733)

  • 1. miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC.
    Feng QQ; Dong ZQ; Zhou Y; Zhang H; Long C
    Bratisl Lek Listy; 2018; 119(1):60-65. PubMed ID: 29405733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X; Liu D; Peng G; Liu J; Yang H
    Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
    Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
    J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
    Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
    Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
    Ge T; Wu HC; Zhou YY; Shen SM; Zhu LG; You GX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5823-5830. PubMed ID: 31298353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-532-3p inhibits metastasis and proliferation of non-small cell lung cancer by targeting FOXP3.
    Jiang W; Zheng L; Yan Q; Chen L; Wang X
    J BUON; 2019; 24(6):2287-2293. PubMed ID: 31983096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
    Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
    Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
    Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer.
    Jiang L; Ge W; Geng J
    Pathol Res Pract; 2019 Dec; 215(12):152705. PubMed ID: 31685299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
    Zhang H; Zhu X; Li N; Li D; Sha Z; Zheng X; Wang H
    Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):496-503. PubMed ID: 25998575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
    Liu B; Li J; Zheng M; Ge J; Li J; Yu P
    Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
    Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
    Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.